Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133348) titled 'Exploratory Study on ADC Combined with Immunotherapy in Recurrent Nasopharyngeal Carcinoma' on Sept. 24.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Eye & ENT hospital of Fudan University

Condition: Blood-stained sputum on suction, ear fullness, and neck mass

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-09-24

Target Sample Size: intervention group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320702

Published by HT Digital Content Services with permission from Health Daily Digest....